International Flavors & F... (IFFT)
NYSE: IFFT
· Real-Time Price · USD
47.56
-1.32 (-2.70%)
At close: Apr 24, 2025, 3:47 PM
International Flavors & Fragrances Revenue Breakdown
| Period Ending | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|
| Health & Biosciences Revenue | 639M | 426M |
| Health & Biosciences Revenue Growth | +50.00% | n/a |
| Nourish Revenue | 1.67B | 162M |
| Nourish Revenue Growth | +929.63% | n/a |
| Pharma Solutions Revenue | 232M | n/a |
| Pharma Solutions Revenue Growth | n/a | n/a |
| Scent Revenue | 550M | n/a |
| Scent Revenue Growth | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Revenue | 707M | 587M | 293.63M | 283.2M | 275.31M | 309.51M | 581.77M | 293.26M | 287.96M | 267.82M | 237.41M | 242.22M | 243.56M |
| Asia Revenue Growth | +20.44% | +99.91% | +3.68% | +2.87% | -11.05% | -46.80% | +98.38% | +1.84% | +7.52% | +12.81% | -1.98% | -0.55% | n/a |
| Emea Revenue | 1.08B | 873M | 499.86M | 481.09M | 463.32M | 543.13M | 1.02B | 528.09M | 529.61M | 508.64M | 285.52M | 292.85M | 309.31M |
| Emea Revenue Growth | +24.17% | +74.65% | +3.90% | +3.83% | -14.69% | -46.96% | +93.92% | -0.29% | +4.12% | +78.14% | -2.50% | -5.32% | n/a |
| Latin America Revenue | 337M | 283M | 173M | 183.03M | 159.62M | 191.29M | 369.76M | 176.3M | 178.78M | 171.32M | 135.95M | 135.89M | 136.91M |
| Latin America Revenue Growth | +19.08% | +63.59% | -5.48% | +14.67% | -16.56% | -48.27% | +109.74% | -1.38% | +4.35% | +26.02% | +0.04% | -0.74% | n/a |
| North America Revenue | 961M | 722M | 303.58M | 320.75M | 300.52M | 303.39M | 575.52M | 293.92M | 301.06M | 271.26M | 248.66M | 249.05M | 241.15M |
| North America Revenue Growth | +33.10% | +137.83% | -5.35% | +6.73% | -0.94% | -47.28% | +95.81% | -2.37% | +10.98% | +9.09% | -0.16% | +3.28% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 412M | 451M | 301.88M | 282.26M | 279.24M | 278.06M | 291.14M | 259.26M | 258.01M | 260.81M | 297.72M | 166.8M | 166.99M | 151.83M | 149.97M | 150.24M | 144.4M | 147.4M | 164.96M | 157.51M | 137.91M | 129.6M | 127M | 127.66M | 134.06M | 120.83M |
| Selling, General, and Administrative Revenue Growth | -8.65% | +49.40% | +6.95% | +1.08% | +0.42% | -4.49% | +12.30% | +0.48% | -1.07% | -12.40% | +78.49% | -0.11% | +9.99% | +1.24% | -0.18% | +4.04% | -2.03% | -10.65% | +4.72% | +14.21% | +6.41% | +2.05% | -0.52% | -4.77% | +10.95% | n/a |
| Research and Development Revenue | 164M | 143M | 100.04M | 89.97M | 80.95M | 85.91M | 85.64M | 85.08M | 84.82M | 90.6M | 83.04M | 75.3M | 74.77M | 78.48M | 75.06M | 70.93M | 70.32M | 69.71M | 63.21M | 64.42M | 63.25M | 63.38M | 57.38M | 62.75M | 62.51M | 63.46M |
| Research and Development Revenue Growth | +14.69% | +42.95% | +11.19% | +11.14% | -5.77% | +0.32% | +0.66% | +0.31% | -6.38% | +9.10% | +10.27% | +0.71% | -4.73% | +4.55% | +5.82% | +0.87% | +0.87% | +10.28% | -1.87% | +1.84% | -0.21% | +10.47% | -8.56% | +0.38% | -1.49% | n/a |